Comparison of the efficacy and safety of bilastine 20 mg <i>vs</i> levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi‐centre, double‐blind, randomized, placebo‐controlled study - Concepedia

Concepedia

Publication | Closed Access

Comparison of the efficacy and safety of bilastine 20 mg <i>vs</i> levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi‐centre, double‐blind, randomized, placebo‐controlled study

144

Citations

27

References

2009

Year

Torsten Zuberbier, A Oanţă, Ewa Bogacka, I. Medina, F. Wesel, Patrizia Uhl, I. Antépara, I Jáuregui, Román Valiente

Abstract

Bilastine 20 mg is a novel effective and safe treatment option for the management of CU.

References

	Year	Citations

Page 1